Innoviva PE Ratio 2006-2020 | INVA

Current and historical p/e ratio for Innoviva (INVA) from 2006 to 2020. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Innoviva PE ratio as of September 25, 2020 is 5.21.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Innoviva PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2020-09-25 10.74 5.21
2020-06-30 13.98 $2.06 6.79
2020-03-31 11.76 $1.71 6.88
2019-12-31 14.16 $1.43 9.90
2019-09-30 10.54 $3.35 3.15
2019-06-30 14.56 $3.42 4.26
2019-03-31 14.03 $3.56 3.94
2018-12-31 17.45 $3.52 4.96
2018-09-30 15.24 $1.63 9.35
2018-06-30 13.80 $1.41 9.79
2018-03-31 16.67 $1.23 13.55
2017-12-31 14.19 $1.11 12.78
2017-09-30 14.12 $0.87 16.23
2017-06-30 12.80 $0.78 16.41
2017-03-31 13.83 $0.60 23.05
2016-12-31 10.70 $0.49 21.84
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $1.089B $0.261B
Innoviva, Inc. is focused on the development, commercialization and financial management of bio-pharmaceuticals. The company's portfolio of respiratory assets partnered with Glaxo Group Limited, including RELVAR(R)/BREO(R) ELLIPTA(R) and ANORO(R) ELLIPTA(R). Innoviva, Inc., formerly known as Theravance, Inc., is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $383.497B 18.28
Roche Holding AG (RHHBY) Switzerland $306.949B 0.00
Merck (MRK) United States $209.750B 14.97
Pfizer (PFE) United States $200.326B 12.52
Novartis AG (NVS) Switzerland $199.369B 15.50
Novo Nordisk (NVO) Denmark $162.622B 26.46
AbbVie (ABBV) United States $152.182B 9.27
AstraZeneca (AZN) United Kingdom $145.679B 28.32
Eli Lilly (LLY) United States $143.719B 21.94
Sanofi (SNY) $127.160B 15.11
GlaxoSmithKline (GSK) United Kingdom $94.822B 12.43
Bayer (BAYRY) Germany $58.527B 8.44
H Lundbeck (HLUYY) Denmark $6.412B 0.00